Publication

Progesterone's role in neuroprotection, a review of the evidence

Downloadable Content

Persistent URL
Last modified
  • 02/25/2025
Type of Material
Authors
    Eric R. Deutsch, Emory UniversityTamara Espinoza, Emory UniversityFahim Atif, Emory UniversityElise Woodall, Emory UniversityJordan Kaylor, Emory UniversityDavid Wright, Emory University
Language
  • English
Date
  • 2013-09-12
Publisher
  • Elsevier
Publication Version
Copyright Statement
  • © 2013 Elsevier B.V.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0006-8993
Volume
  • 1530
Start Page
  • 82
End Page
  • 105
Abstract
  • The sex hormone progesterone has been shown to improve outcomes in animal models of a number of neurologic diseases, including traumatic brain injury, ischemia, spinal cord injury, peripheral nerve injury, demyelinating disease, neuromuscular disorders, and seizures. Evidence suggests it exerts its neuroprotective effects through several pathways, including reducing edema, improving neuronal survival, and modulating inflammation and apoptosis. In this review, we summarize the functional outcomes and pathophysiologic mechanisms attributed to progesterone treatment in neurologic disease. We then comment on the breadth of evidence for the use of progesterone in each neurologic disease family. Finally, we provide support for further human studies using progesterone to treat several neurologic diseases.
Author Notes
  • Address correspondence and reprints to David W. Wright, Emergency Neuroscience, Department of Emergency Medicine, Emory University, FOB Suite 126, 49 Jesse Hill Jr. Drive SE, Atlanta, GA 30303. Phone: 404­778­1709 Fax: 404­778­1604.  E­mail: david.wright@emory.edu
Keywords
Research Categories
  • Health Sciences, Medicine and Surgery
  • Health Sciences, General
  • Health Sciences, Rehabilitation and Therapy

Tools

Relations

In Collection:

Items